PT Asuransi Jiwa Sinarmas MSIG Tbk (LIFE.JK)
IDR 7000.0
(4.87%)
IDR 7000.0
(4.87%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 164.68 Billion IDR | -91.98% |
| 2022 | 394.82 Billion IDR | 160.54% |
| 2021 | 110.92 Billion IDR | -60.29% |
| 2020 | 384.4 Billion IDR | 8.33% |
| 2019 | 322.93 Billion IDR | -1.63% |
| 2018 | 361.48 Billion IDR | -23.98% |
| 2017 | 485.12 Billion IDR | 4.71% |
| 2016 | 447.6 Billion IDR | 275.07% |
| 2015 | 140.88 Billion IDR | 216.44% |
| 2014 | 44.52 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 16.22 Billion IDR | -100.0% |
| 2024 Q3 | 82.88 Billion IDR | 0.0% |
| 2024 Q1 | 99.45 Billion IDR | 0.0% |
| 2023 Q2 | 85.33 Billion IDR | -9.46% |
| 2023 Q3 | 19.77 Billion IDR | -76.82% |
| 2023 FY | - IDR | -91.98% |
| 2023 Q4 | 8.45 Billion IDR | -57.26% |
| 2023 Q1 | 94.25 Billion IDR | -39.34% |
| 2022 Q3 | 75.27 Billion IDR | -14.54% |
| 2022 FY | - IDR | 160.54% |
| 2022 Q1 | 159.44 Billion IDR | 6879.21% |
| 2022 Q2 | 88.08 Billion IDR | -44.76% |
| 2022 Q4 | 155.36 Billion IDR | 106.41% |
| 2021 Q1 | 109.72 Billion IDR | -15.87% |
| 2021 FY | - IDR | -60.29% |
| 2021 Q4 | -2.35 Billion IDR | -113.89% |
| 2021 Q3 | 16.93 Billion IDR | -77.04% |
| 2021 Q2 | 73.75 Billion IDR | -32.78% |
| 2020 Q2 | 120.29 Billion IDR | 11.01% |
| 2020 Q3 | 105.88 Billion IDR | -11.98% |
| 2020 Q1 | 108.36 Billion IDR | 131.51% |
| 2020 FY | - IDR | 8.33% |
| 2020 Q4 | 130.42 Billion IDR | 23.17% |
| 2019 Q2 | 149.02 Billion IDR | 27.86% |
| 2019 Q3 | 86.98 Billion IDR | -41.63% |
| 2019 Q4 | 46.8 Billion IDR | -46.19% |
| 2019 Q1 | 116.55 Billion IDR | 4.87% |
| 2019 FY | - IDR | -1.63% |
| 2018 Q4 | 111.13 Billion IDR | 209.0% |
| 2018 Q2 | 61.82 Billion IDR | 0.0% |
| 2018 Q1 | - IDR | -100.0% |
| 2018 FY | - IDR | -23.98% |
| 2018 Q3 | 35.96 Billion IDR | -41.83% |
| 2017 Q3 | - IDR | 0.0% |
| 2017 Q2 | - IDR | 0.0% |
| 2017 Q1 | - IDR | 100.0% |
| 2017 FY | - IDR | 4.71% |
| 2017 Q4 | 7.92 Billion IDR | 0.0% |
| 2016 FY | - IDR | 275.07% |
| 2016 Q2 | - IDR | 0.0% |
| 2016 Q3 | 1 Billion IDR | 0.0% |
| 2016 Q1 | - IDR | 0.0% |
| 2016 Q4 | -52.97 Billion IDR | -5355.32% |
| 2015 FY | - IDR | 216.44% |
| 2014 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Pacific Strategic Financial Tbk | 181.88 Billion IDR | 9.454% |
| PT Bhakti Multi Artha Tbk | 23.6 Billion IDR | -597.661% |
| PT Capital Financial Indonesia Tbk | 1379.34 Billion IDR | 88.06% |
| PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk | -926.95 Million IDR | 17866.545% |
| PT Paninvest Tbk | 10197.29 Billion IDR | 98.385% |
| PT Panin Financial Tbk | 10261.96 Billion IDR | 98.395% |